The MATISSEDVT trial, a randomized, double-blind study comparing once-daily fondaparinux (Arixtra) with the low-molecular weight heparin (LMWH) enoxaparin, twice daily, in the initial treatment of symptomatic deep-vein thrombosis (DVT) - The MATISSE Investigators (Thromb Haemost, 2003)